CEO & President
Jay Galeota is President and Chief Executive Officer of Kallyope and serves on our Board of Directors. Jay is one of the few leaders in biopharma whose depth of experience spans large pharmaceutical companies, specialty generics, new company spin-offs, and biotech startups. He is known for his passion for innovation and development of breakthrough products and business opportunities. Prior to joining Kallyope, Jay was President and Chief Executive Officer of Inheris BioPharma and previously served as President of G&W Laboratories. The first 28 years of Jay’s career were at Merck & Co., Inc. where he rose to the position of Chief Strategy & Business Development Officer and President, Emerging Business for the company. During his career at Merck, Jay held diverse positions across commercial operations, business development, strategy, and innovation, globally and in the United States. Jay holds a Bachelor of Science in biology from Villanova University and is a graduate of Harvard Business School’s Advanced Management Program. In addition to Kallyope, Jay serves on the board of Gandeeva Therapeutics and served as an Independent Director at Melinta Therapeutics (MLNT) and Assertio Therapeutics (ASRT). He is also on the boards of Hackensack Meridian Health System and Harvard Business School’s Healthcare Alumni Association, serving as an officer on both. Jay also currently serves as Honorary Commander of the United States Air Force 113th Wing and was a member of Villanova University’s Dean's Advisory Council. Jay is the co-author of several publications in Harvard Business Review and Chief Executive and has been a guest lecturer at the Wharton School of the University of Pennsylvania and Columbia Business School.